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LETTERS TO THE EDITOR
Failure of Topical Estrogen Receptor Agonists and Antagonists
to Alter Murine Hair Follicle Cycling
To the Editor:
In October 1996 there appeared a publication by Oh and Smart
describing experiments that were interpreted to indicate an important
estrogen receptor regulation of hair growth. This report was well
publicized and stimulated a worldwide response.
In essence, the report indicated that in the CD-1 female mouse
topical 17β estradiol, but not 17α estradiol, blocks anagen induction
and that the estrogen receptor antagonist, ICI 182780, induces anagen.
This finding was of major interest to us in the field of hair biology
because the conclusions implied that the hair growth cycle is under
negative control, an idea that we have previously considered (Paus
et al, 1990, 1991; Stenn et al, 1993). For this reason we made a
concentrated attempt in two independent and widely separated laborat-
ories to reproduce the experiments as they were described. At the
outset we recognized that the putative capacity of 17β estradiol to
‘‘arrest’’ hair follicles in telogen as suggested by Oh and Smart
contradicted the clinical use of topical estradiol for the successful
treatment of telogen effluvium in humans, presumably by prolonging
the duration of anagen (Orfanos and Vogel, 1980).
In our studies we used two pigmented female mouse strains, C57BL/
6 and C3H, because (i) we wanted to test the phenomenon in two
different mouse strains, and (ii) we have found that careful hair cycle
studies using a nonpigmented animal, such as the CD-1 mouse, are
very difficult to interpret.
In Experiment I, we treated the animals following the Oh/Smart
protocol precisely. For the induction study hair-clipped animals were
treated twice weekly for 7 wk [ICI 182780, 10 nM, as well as
Tamoxifen, 10 nM (Sigma, St Louis, MO)]. For the inhibition studies,
anagen was depilatory-cream-induced (NeetTM) and the mice were
treated twice weekly with 17α estradiol (10 nM, Sigma) or 17β
estradiol (10 nM, Sigma) for 2 wk. In addition, we treated hair-clipped
mice with all back skin follicles in telogen, and treated them with
either 17β estradiol, 17α estradiol, or vehicle alone, twice weekly for
5 wk. Each experimental group contained 5–7 mice and was repeated
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On Photo-Stability of Oxybenzone
To the Editor:
I refer to a paper by Schallreuter et al. (1996) entitled ‘‘Oxybenzone
oxidation following solar irradiation of skin: photoprotection versus
antioxidant inactivation’’ that was published in the March issue of
Journal of Investigative Dermatology. In this paper it is suggested that
oxybenzone (2-hydroxy-4-methoxy benzophenone) is unstable to
sunlight: there is a significant increase of the CO group concentration
indicative of the oxidation of oxybenzone to its semiquinone. This
conclusion encouraged us to perform some investigation by Fourier
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once. On completion, in no experiment were the treated mice
significantly different from the controls.
In Experiment II, the estradiol studies were repeated using the same
preparations as in Experiment I but the drugs were applied daily for
2 wk. Again, experimental animals showed no difference from controls.
In Experiment III, conditions were identical to Experiment I but the
applications of the receptor antagonists [ICI 182780 or Tamoxifen,
10 nM (Sigma)] or the agonists (17α estradiol and 17β estradiol) were
given daily for 20 d (antagonists) and 9 d (agonists). Again, the
experimental mice showed no difference from the controls.
It is always difficult to interpret a negative result. One possibility in
explaining these discrepancies is that the phenomena described are
unique to the animal strain used, namely, CD-1. Nevertheless, whatever
the complete explanation for the differences observed in the three
laboratories, the experiments reported here indicate that the estrogen
effects are not applicable to two of the mouse strains routinely used in
hair research, and conflict with common clinical experience. The Oh
and Smart (1996) conclusions on the role of estrogen receptor
stimulation or blockade in hair growth control therefore will require
rigorous further testing and analysis before they can be critically
accepted.
Kurt S. Stenn, R. Paus,* M. Filippi
Skin Biology Research Center, Johnson and Johnson
Skillman, New Jersey, U.S.A.
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Transform Infrared Spectroscopy (FTIR) on the stability to light of
oxybenzone.
An acetone solution of the product was deposited on sodium
chloride windows and on a KRS-5 crystal. The solvent was evaporated
and a very thin layer of the product obtained. The layer on the crystal
was exposed to sunlight for 2 h and the layer on the sodium choride
windows was exposed to light in a Suntest CPS1 apparatus (Xenotest
GmbH, Hanau, D) for 15 h. The multiple internal reflectance FTIR
spectrum of the layer on the crystal and the transmission FTIR
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Figure 1. Oxybenzone on NaCl windows, FTIR spectra before (1) and
after (2) exposure to light (15 h, Suntest CPS1, Xenon test, 500 Watt
per m2).
spectrum of the layer on the sodium chloride windows were recorded,
before and after exposure to light, on a P.E. System 2000 instument
(Perkin Elmer, Beaconsfield, U.K.).
In both cases no change in the intensities of the carbonyl stretching
bands or other changes in the IR spectrum were observed; Fig 1
shows the transmission FTIR spectra (i) before and (ii) after exposure
to light.
Both experiments show that oxybenzone is very stable under light
and no significant semiquinone is generated.
Finally, if Fig 1 of Schallreuter et al. (1996) is considered it seems
that oxybenzone itself is absent in the Sultan facial cream as many of
the oxybenzone absorbances are not present in the FT Raman spectrum
of the cream. This observation, together with the results of our
investigation, lead us to suspect that the study described in the paper
has not been performed on oxybenzone, but on some other product.
Ettore Santoro
3V Sigma, Bergamo, Italy
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Reply:
We wish to respond to Dr. Santoro’s comment on our paper
‘‘Oxybenzone oxidation following solar irradiation of skin:
photoprotection versus antioxidant inactivation’’ (Schallreuter et al,
1996). There are two major points to address: (i) the stability of
oxybenzone to photo-oxidation in sun protection formulations, and
(ii) whether the Soltan facial cream as used in the above study indeed
contained oxybenzone.
High performance liquid chromatography (HPLC) of Soltan facial
cream SPF 25 purchased in June 1995, proves the presence of
oxybenzone as claimed on the label of this product (Fig 1A). The
absence of some Raman absorbances in Soltan facial cream has been
elucidated in more detail and is most likely due to pi–pi interactions
with other aromatic compounds such as Parsol 1789 and Parsol MCX.
HPLC analysis of the recovery of oxybenzone after ultraviolet (UV)
exposure (5 d exposure time) shows 80% photodegradation of this
ultraviolet A (UVA) filter (Fig 1B). Recently, Heinsohn et al1 claimed
1Heinsohn G, Rapp C, Gers-Barlag H: FT-Raman Spectroscopy – a suitable
method for photostablility testing of sunscreens. International Conference on
Photobiology, Vienna (September 1996).
Figure 1. (A) HPLC profile with retention time for oxybenzone from
Soltan Facial SPF 25 cream. A 250 nm Spherisorb ODS2 column with a
bead size of 5 µm was used together with a gradient of 80% methanol: 20%
0.05 M ortho phosphoric acid solution to 100% methanol over 15 min and a
flow rate of 1 ml per min. Rainin FPLC/HPLC Dynamax SD 300 Solvent
Delivery Systems and Dynamax UV-1 detector (Anachem, Luton, U.K.) were
employed with UV detection at 334 nm. (B) The effect of UV exposure on
SPF 25 sunscreen product examined by HPLC. The UV filter oxybenzone
was studied before and after exposure to normal sunlight. Composition of
oxybenzone in the cream was established and compared daily using a freshly
prepared standard. The results are based on the mean of three analyses.
Figure 2. FT Raman spectra of Soltan sun lotion containing 3.83%
oxybenzone (a) before ultraviolet B (UVB) irradiation, (b) after
0.3 J UVB irradiation per cm2, and (c) after 0.9 J UVB irradiation per
cm2. The peaks are assigned as aromatic ring stretches with the mono-
substituted ring stretch at 1598 per cm and the 1,2,4-tri-substituted aromatic
ring stretch at 1625 per cm. After 0.3 J UVB irradiation per cm2, there is a 9%
decrease in the intensity of the 1,2,4-tri-substituted ring stretch indicating a
loss of aromaticity with no effect on the mono-substituted ring stretch. After
0.9 J irradiation per cm2, there is a considerable decrease in both tri-and mono-
substituted ring stretches showing a loss of aromaticity in the ring structures of
oxybenzone.
